A new study has found that liraglutide, an injectable treatment for Type 2 diabetes, can improve blood glucose control and increase weight loss in people with Type 2 diabetes.
Researchers at Houston College of Medicine looked at 746 people with early Type 2 diabetes, who were either given the injection liraglutide or the tablet glimepiride, for one year.
Improved blood glucose control
The findings, published in 'The Lancet' this week, showed that those given the injection benefited from improved blood glucose control with a low rate of hypoglycaemia. In addition, participants taking liraglutide lost on average 5lb over a year, while those taking the tablet put on 2lb.
Managing diabetes effectively
"Diabetes UK closely follows all research into new developments for treating Type 2 diabetes," said Libby Dowling, Care Advisor at leading health charity Diabetes UK.
"Offering a choice of appropriate treatments for people with the condition is essential to help them manage their diabetes effectively and reduce their risk of serious complications. However, all treatments must be supported by robust research."